In a study by Campos and colleagues, two O-glycoproteins, CD44 and GalNAc-T5 with O-glycan STn were observed in both GC cells and sera of patients with GC, and indicated as potential biomarkers in gastric cancer [76]. This evidence concerns the gene CD44 and gastric cancer.